Literature DB >> 33392135

The Role of Traditional Chinese Medicine in Arthritis Management: Why We Need Public Health and Health Services Research.

Lu Yang1, Jon Adams2.   

Abstract

Entities:  

Keywords:  arthritis; care management; health services research; public health; traditional Chinese medicine

Mesh：

Year:  2020        PMID： 33392135      PMCID： PMC7773773          DOI： 10.3389/fpubh.2020.597917

Source DB:  PubMed          Journal:  Front Public Health        ISSN： 2296-2565


× No keyword cloud information.
  12 in total

1.  The Role of CAM in Public Health, Disease Prevention, and Health Promotion.

Authors:  Cheryl Hawk; Jon Adams; Jan Hartvigsen
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-24       Impact factor: 2.629

2.  Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: A nationwide population-based study.

Authors:  Ming-Cheng Huang; Fu-Tzu Pai; Che-Chen Lin; Ching-Mao Chang; Hen-Hong Chang; Yu-Chen Lee; Mao-Feng Sun; Hung-Rong Yen
Journal:  J Ethnopharmacol       Date:  2015-10-23       Impact factor: 4.360

3.  ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems.

Authors:  Wai Ching Lam; Aiping Lyu; Zhaoxiang Bian
Journal:  Pharmaceut Med       Date:  2019-10

Review 4.  A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.

Authors:  Lu Yang; David Sibbritt; Jon Adams
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

5.  Complementary and alternative medicine (CAM) among Australian hospital-based nurses: knowledge, attitude, personal and professional use, reasons for use, CAM referrals, and socio-demographic predictors of CAM users.

Authors:  Seyed Afshin Shorofi; Paul Arbon
Journal:  Complement Ther Clin Pract       Date:  2017-03-30       Impact factor: 2.446

Review 6.  Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis.

Authors:  Xiu-Min Chen; Run-Yue Huang; Qing-Chun Huang; Yong-Liang Chu; Jing-Yao Yan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

7.  Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis.

Authors:  H Foley; A Steel; H Cramer; J Wardle; J Adams
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

Review 8.  Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis.

Authors:  Qi Xing; Ling Fu; Zhichao Yu; Xueping Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-02       Impact factor: 2.629

9.  Acupuncture, chiropractic and osteopathy use in Australia: a national population survey.

Authors:  Charlie C L Xue; Anthony L Zhang; Vivian Lin; Ray Myers; Barbara Polus; David F Story
Journal:  BMC Public Health       Date:  2008-04-01       Impact factor: 3.295

10.  Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: analysis of data from the World Health Organization study on global AGEing and adult health (SAGE) Wave 1.

Authors:  Sharon L Brennan-Olsen; S Cook; M T Leech; S J Bowe; P Kowal; N Naidoo; I N Ackerman; R S Page; S M Hosking; J A Pasco; M Mohebbi
Journal:  BMC Musculoskelet Disord       Date:  2017-06-21       Impact factor: 2.362
View more
  2 in total

1.  Global Trade Pattern of Traditional Chinese Medicines and China's Trade Position.

Authors:  Liyao Xiang; Zaoyu Chen; Shaobin Wei; Haiyan Zhou
Journal:  Front Public Health       Date:  2022-04-28

Review 2.  Implementation of Best-Evidence Osteoarthritis Care: Perspectives on Challenges for, and Opportunities From, Low and Middle-Income Countries.

Authors:  Jillian P Eyles; Saurab Sharma; Rosa Weiss Telles; Mosedi Namane; David J Hunter; Jocelyn L Bowden
Journal:  Front Rehabil Sci       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.